Collplant Company

CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Rehovot, Israel.
Technology: Organ Engineering
Industry: Regenerative medicine
Headquarters: Others
Employees Number: 11-50
Funding Status: IPO

Visit Website
info@collplant.com
https://twitter.com/CollplantBio
Register and Claim Ownership